2026
article
OpenAlex
Alexander Damanakis, Georg Dieplinger, Angela Ernst, Patricia Wyzlic et autres
BACKGROUND: Rectal cancer is one of the most common cancers in the Western world. The path toward personalized treatments in medicine includes further determination of sex-associated differences. OBJECTIVE: The objective of this study is to explore sex-related differences in the outcome of …
de
(code pays fourni par la source)
2025
article
OpenAlex
Patricia Wyzlic, Alexander Damanakis, Lars M. Schiffmann, Nikolai Schleußner et autres
de
(code pays fourni par la source)
2025
article
OpenAlex
Alexander Damanakis, Kevin T Jamouss, Abigail C. Cornwell, Martine Jongepier et autres
us, de, nl
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Alexander T.F. Bell, Peter Chianchiano, Katsuya Hirose, Daniel James Salas-Escabillas et autres
In pancreatic ductal adenocarcinoma (PDAC), venous invasion (VI) is a critical step in metastasis and is associated with poor survival. However, little is known about the molecular features of VI. To investigate, we performed spatial transcriptomic analysis of 95 human PDAC tissue …
us
(code pays fourni par la source)
2025
conference-paper
OpenAlex
I Kreutzer, A. Abu Hejleh, Naita M. Wirsik, Alexander Damanakis et autres
Background and Aims: Ivor-Lewis esophagectomy remains one of the most complex oncologic procedures with overall postoperative complications of around 60%. Over one third of all patients suffer from complications that require at least endoscopic or other interventional therapy even in high volume …
de
(code pays fourni par la source)
2025
conference-paper
OpenAlex
Nikolai Schleußner, Christian Goddemeier, D Puhleva, Ella Leugner et autres
Background: The Activator Protein-1 (AP-1) transcription factors are expressed in many cancer entities and are correlated to deregulated transcription factor networks including dedifferentiation and therapy resistance. They are involved in key functions of the cellular biology and maintain and adjust the transcriptional …
de
(code pays fourni par la source)
Accès ouvert
2025
conference-abstract
OpenAlex
Dirk Waldschmidt, Nam Gyu Im, Alexander Damanakis, Thomas Schmidt et autres
4172 Background: Aim of the prospective single arm HOLIPANC trial (NCT04617457) is to evaluate the efficacy and safety of multimodal treatment in pancreatic oligometastatic disease. Methods: Patients with hepatic oligometastatic pancreatic cancer receive up to 8 cycles of a combination of liposomal …
de
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Julian Lemties, Carolin Scheidt, Jin‐On Jung, Naita M. Wirsik et autres
BACKGROUND: Anastomotic leakage (AL) contributes to postoperative morbidity and mortality after Ivor-Lewis esophagectomy. Vascular high-risk patients show a significantly increased risk of AL. We previously showed that laparoscopic ischemic conditioning (ISCON) of the stomach prior esophagectomy in these high-risk patients is a …
de
(code pays fourni par la source)
2025
article
OpenAlex
Alexander Damanakis, Hans F. Fuchs, Christoph Kahlert, Thomas Schmidt
de
(code pays fourni par la source)
2025
article
OpenAlex
Patricia Wyzlic, Alexander Damanakis, Alexander Quaas, Christiane J. Bruns et autres
de
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Kevin T Jamouss, Alexander Damanakis, Abigail C. Cornwell, Martine Jongepier et autres
Pancreatic ductal adenocarcinoma (PDAC) poses a significant challenge due to late-stage diagnoses. To improve patient outcomes, early intervention in precursor lesions such as intraductal papillary mucinous neoplasm (IPMN) is crucial. However, early intervention must be balanced against overtreatment of low-risk lesions that …
us, nl
(code pays fourni par la source)
2024
article
OpenAlex
Friederike Baehr, Johanna Teloh-Benger, Alexander Damanakis, Florian Gebauer et autres
de, us
(code pays fourni par la source)